CDC revealed nationally representative estimates of chronic fatigue; the proposed merger between Cigna and Humana has been terminated over financial terms and shareholder skepticism; ChatGPT provides inaccurate responses to medication queries.
The CDC has unveiled the first nationally representative estimate of US adults living with chronic fatigue syndrome, totaling 3.3 million individuals, according to the Associated Press. The number, larger than previously thought, includes patients with long COVID, shedding light on the condition's prevalence. The report challenges stereotypes, revealing that chronic fatigue is not confined to a specific demographic, as both men and women across various racial and economic groups report its debilitating effects, emphasizing the need for increased awareness and understanding.
Cigna has halted its pursuit of a $140 billion merger with competitor Humana following unsuccessful negotiations and shareholder apprehensions, as reported by The Wall Street Journal. Shareholders expressed reservations about the proposed cash-and-stock transaction, causing a nearly 10% drop in Cigna's stock. While Cigna remains supportive of the potential benefits of a merged entity, the company now shifts its focus to smaller acquisitions and plans $10 billion in stock buybacks.
A study conducted by researchers at Long Island University has uncovered limitations in the ability of ChatGPT, an artificial intelligence (AI) chatbot, to address medical queries accurately, according to CNN. The research, presented at the annual meeting of the American Society of Health-System Pharmacists, compared the chatbot's responses to 39 medication-related questions against those from trained pharmacists and found that only about 10 questions received accurate responses. Furthermore, the study revealed that ChatGPT provided fabricated references for some responses, raising concerns about potential risks and emphasizing the importance of relying on professional medical advice rather than AI for health-related concerns.
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More